Lupin Ltd LUPIN-IN:National Stock Exchange of India
*Data is delayed | Exchange | INR
Last | 4:43 PM IST
1,652.75
-11.20 (-0.67%)
-11.20 (-0.67%)Volume
721,714
52 week range
769.60 - 1,704.25
- Open1,671.85
- Day High1,681.25
- Day Low1,638.25
- Prev Close1,662.95
- 52 Week High1,704.25
- 52 Week High Date03/11/24
- 52 Week Low769.60
- 52 Week Low Date05/22/23
Key Stats
- Market Cap8,775.17M
- Shares Out455.75M
- 10 Day Average Volume1.7M
- Dividend4.00
- Dividend Yield0.24%
- Beta-
- YTD % Change25.96
KEY STATS
- Open1,671.85
- Day High1,681.25
- Day Low1,638.25
- Prev Close1,662.95
- 52 Week High1,704.25
- 52 Week High Date03/11/24
- 52 Week Low769.60
- 52 Week Low Date05/22/23
- Market Cap8,775.17M
- Shares Out455.75M
- 10 Day Average Volume1.7M
- Dividend4.00
- Dividend Yield0.24%
- Beta-
- YTD % Change25.96
RATIOS/PROFITABILITY
- EPS (TTM)-
- P/E (TTM)-
- Fwd P/E (NTM)-
- EBITDA (TTM)-
- ROE (TTM)-
- Revenue (TTM)-
- Gross Margin (TTM)-
- Net Margin (TTM)-
- Debt To Equity (MRQ)-
EVENTS
- Earnings Date-
- Ex Div Date07/14/2023
- Div Amount4.00
- Split Date-
- Split Factor-
Latest On Lupin Ltd
Content From Our Affiliates
There is no recent news for this security.
Related Video
watch now
Profile
MORELupin Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti Inflammatory Drug therapy segments and is engaged in the Anti-TB and...
Manju Gupta
Non-Executive Chairman of the Board
Vinita Gupta
Chief Executive Officer, Executive Director
Ramesh Swaminathan
Executive Director, Global Chief Financial Officer, Chief Risk Officer, Head - Corporate Affairs
Address
B/4 Laxmi Towers
, Bandra Kurla Complex, Bandra (E)
Mumbai
400055
India